Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients

American Journal of Transplantation

Volumn 11, Issue 6, 2011, Pages 1218-1225

  Ison, M G ^a   Llata, E ^b,c   Conover, C S ^d   Friedewald, J J ^a   Gerber, S I ^e   Grigoryan, A ^c   Heneine, W ^f   Millis, J M ^g   Simon, D M ^g   Teo, C G ^c,h   Kuehnert, M J ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d ILLINOIS DEPARTMENT OF PUBLIC HEALTH   (United States)

^e University of Chicago ^*  (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Donor to host transmission; HCV; HIV; nucleic acid diagnostics

Indexed keywords

ALANINE AMINOTRANSFERASE; ALEMTUZUMAB; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BASILIXIMAB; CORTICOSTEROID; DACLIZUMAB; EFAVIRENZ; EMTRICITABINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LAMIVUDINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEIC ACID; PEGINTERFERON ALPHA2A; PREDNISONE; RIBAVIRIN; RITUXIMAB; TACROLIMUS; TENOFOVIR; THYMOCYTE ANTIBODY; VIRUS RNA; ZIDOVUDINE;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CD4 LYMPHOCYTE COUNT; ENZYME IMMUNOASSAY; FEMALE; GENE CLUSTER; GENE SEQUENCE; GLOMERULONEPHRITIS; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HEAD INJURY; HEART GRAFT; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRANSAMINASEMIA; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; ISCHEMIC CARDIOMYOPATHY; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER GRAFT; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MALE; MALE HOMOSEXUAL; MEDICAL RECORD REVIEW; MULTIPLE ORGAN FAILURE; NEPHRECTOMY; NEPHROTIC SYNDROME; NUCLEOTIDE SEQUENCE; ORGAN DONOR; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SERODIAGNOSIS; TRAFFIC ACCIDENT; TREATMENT DURATION; UREMIA; VIRUS ISOLATION; VIRUS LOAD; VIRUS TRANSMISSION; WESTERN BLOTTING;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HIV INFECTIONS; HUMANS; ORGAN TRANSPLANTATION; RISK FACTORS; TISSUE DONORS;

EID: 79958856464     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03597.x     Document Type: Article

References (40)

1. Groth CG, Brent LB, Calne RY, et al,. Historic landmarks in clinical transplantation: Conclusions from the consensus conference at the University of California, Los Angeles. World J Surg 2000; 24: 834-843. (Pubitemid 30437482)
2. Starzl TE,. History of clinical transplantation. World J Surg 2000; 24: 759-782. (Pubitemid 30437472)
3. Ison MG, Hager J, Blumberg E, et al,. Donor-derived disease transmission events in the United States: Data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009; 9: 1929-1935.
4. Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody: North Carolina. MMWR Morb Mortal Wkly Rep 1987; 36: 306-308.
5. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994; 43: 1-17.
6. Natov SN,. Transmission of viral hepatitis by kidney transplantation: Donor evaluation and transplant policies (Part 2: Hepatitis C virus). Transpl Infect Dis 2002; 4: 124-131. (Pubitemid 35364775)
7. Quarto M, Germinario C, Fontana A, Barbuti S,. HIV transmission through kidney transplantation from a living related donor. N Engl J Med 1989; 320: 1754. (Pubitemid 19163136)
8. Samuel D, Castaing D, Adam R, et al,. Fatal acute HIV infection with aplastic anaemia, transmitted by liver graft. Lancet 1988; 1: 1221-1222.
9. Simonds RJ, Holmberg SD, Hurwitz RL, et al,. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992; 326: 726-732.
10. OPTN Policy 4. Accessed on March 16, 2011.
11. McNulty A, Jennings C, Bennett D, et al,. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J Clin Microbiol 2007; 45: 517-521.
12. Schochetman GS, Subbarao S, Kalish ML,. Methods for studying genetic variation of the human immunodeficiency virus (HIV). Boca Raton, FL: CRC Press, 1996.
13. Yang C, Pieniazek D, Owen SM, et al,. Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol 1999; 37: 2581-2586. (Pubitemid 29337282)
14. Shafer RW, Jung DR, Betts BJ, Xi Y, Gonzales MJ,. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 2000; 28: 346-348. (Pubitemid 30047803)
15. Ramachandran S, Xia G, Nainan OV, Khudyakov Y,. Temporal patterns of quasispecies in chronic HCV infected patients. In: 12th International Symposium on Viral Hepatitis and Liver Disease; 2006; Paris, France.
16. Ramachandran S, Xia GL, Ganova-Raeva LM, Nainan OV, Khudyakov Y,. End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: Performance under optimal and suboptimal conditions. J Virol Methods 2008; 151: 217-224.
17. Ahn J, Cohen SM,. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 2008; 14: 1603-1608.
18. OPTN Policy 2.2. Accessed on March 16, 2011.
19. Fischer SA, Graham MB, Kuehnert MJ, et al,. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006; 354: 2235-2249. (Pubitemid 43788138)
20. Iwamoto M, Jernigan DB, Guasch A, et al,. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348: 2196-2203. (Pubitemid 36618130)
21. Srinivasan A, Burton EC, Kuehnert MJ, et al,. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352: 1103-1111. (Pubitemid 40365351)
22. Humar A, Morris M, Blumberg E, et al,. Nucleic acid testing (NAT) of organ donors: Is the 'best' test the right test? A consensus conference report. Am J Transplant 2010; 10: 889-899.
23. Merion RM,. 2008 SRTR Report on the State of Transplantation. Am J Transplant 2009; 9: 867-868.
24. Briceno J, Ciria R, Pleguezuelo M, et al,. Contribution of marginal donors to liver transplantation for hepatitis C virus infection. Transplant Proc 2007; 39: 2297-2299. (Pubitemid 47418216)
25. Gambino G, Gioviale MC, Maione C, et al,. Use of marginal donors in kidney transplantation: Our experience. Transplant Proc 2006; 38: 999-1000. (Pubitemid 43815892)
26. Boggi U, Del Chiaro M, Vistoli F, et al,. Pancreas transplantation from marginal donors. Transplant Proc 2004; 36: 566-568. (Pubitemid 38534324)
27. Berman M, Ben-Gal T, Georghiou GP, et al,. Outcome of marginal donors in heart transplantation. Transplant Proc 2003; 35: 675-676. (Pubitemid 36338111)
28. Schweitzer EJ, Perencevich EN, Philosophe B, Bartlett ST,. Estimated benefits of transplantation of kidneys from donors at increased risk for HIV or hepatitis C infection. Am J Transplant 2007; 7: 1515-1525. (Pubitemid 46776240)
29. Ison MG, Stosor V,. Transplantation of high-risk donor organs: A survey of US solid organ transplant center practices as reported by transplant infectious diseases physicians. Clin Transplant 2009; 23: 866-873.
30. Tugwell BD, Patel PR, Williams IT, et al,. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005; 143: 648-654.
31. Aswad S, Khan NS, Comanor L, et al,. Role of nucleic acid testing in cadaver organ donor screening: Detection of hepatitis C virus RNA in seropositive and seronegative donors. J Viral Hepat 2005; 12: 627-634. (Pubitemid 41532494)
32. Kucirka LM, Singer AL, Ros RL, Montgomery RA, Dagher NN, Segev DL,. Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients. Am J Transplant 2010; 10: 1238-1246.
33. Palacios G, Druce J, Du L, et al,. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008; 358: 991-998. (Pubitemid 351347098)
34. Fishman JA, Strong DM, Kuehnert MJ,. Organ and tissue safety workshop 2007: Advances and challenges. Cell Tissue Bank 2009; 10: 271-280.
35. Schmidt HA, Strimmer K, Vingron M, von Haeseler A,. TREE-PUZZLE: Maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 2002; 18: 502-504. (Pubitemid 34284960)
36. Thompson JD, Higgins DG, Gibson TJ,. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22: 4673-4680. (Pubitemid 24354800)
37. Posada D, Buckley TR,. Model selection and model averaging in phylogenetics: Advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. Syst Biol 2004; 53: 793-808. (Pubitemid 39568279)
38. Drummond AJ, Rambaut A,. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 2007; 7: 214-221.
39. Jafa K, McElroy P, Fitzpatrick L, et al,. HIV transmission in a state prison system, 1988-2005. PLoS One 2009; 4: e5416.
40. Robbins KE, Weidle PJ, Brown TM, et al,. Molecular analysis in support of an investigation of a cluster of HIV-1-infected women. AIDS Res Hum Retroviruses 2002; 18: 1157-1161. (Pubitemid 35191778)